Two Pseudomonas aeruginosa genes encoding the enzymes 1-deoxy-D-xylulose 5-phosphate (DXP) synthase and DXP reductoisomerase, both involved in the mevalonate-independent biosynthesis of isoprenoids, have been expressed as recombinant enzymes in Escherichia coli. The purified P. aeruginosa DXP reductoisomerase was inhibited by submicromolar concentrations of the antibiotics fosmidomycin and FR-900098 in a well established method. A novel and convenient spectrophotometric assay was developed to determine activity and inhibition of P. aeruginosa DXP synthase. Fluoropyruvate is described as a first inhibitor of DXP synthase. ß
Introduction
Pseudomonas aeruginosa is an important bacterial pathogen in humans. Hospitalized patients like burn victims, individuals with cancer and those with cystic ¢brosis are particularly at risk of infection. Because antibiotics are often ine¡ective against this pathogen, infections are di¤-cult to treat [1] . New antibiotics with higher e¤ciency and fewer side e¡ects are urgently needed.
In earlier studies it was shown that the antibiotic fosmidomycin, originally isolated from Streptomyces lavendulae, e¤ciently inhibits the growth of P. aeruginosa [2] and was well tolerated in volunteers [3] . However, the molecular target of fosmidomycin was unknown. Recently, it was demonstrated that fosmidomycin is an e¤cient inhibitor of 1-deoxy-D-xylulose 5-phosphate (DXP) reductoisomerase from Plasmodium falciparum and Escherichia coli [4, 5] , one of the enzymes involved in the biosynthesis of isoprenoids through the mevalonate-independent DXP pathway which is present in many eubacteria, algae, chloroplasts of higher plants, and malaria parasites [4, 6, 7] . In many of the respective bacteria including P. aeruginosa the DXP pathway represents the only source of isopentenyl pyrophosphate (IPP), the universal precursor of isoprenoids [8] .
The biochemical reactions of the DXP pathway have not been elucidated completely yet. The initial step, the formation of DXP by condensation of pyruvate and Dglyceraldehyde 3-phosphate, is catalyzed by DXP synthase [9^12] in a thiamine-dependent way (Fig. 1) . In a second step, DXP is converted by DXP reductoisomerase into 2-C-methyl-D-erythritol 4-phosphate (MEP) in the presence of NADPH. According to recent work [13, 14] , a cytidyl residue is added to MEP leading to 4-(cytidine 5P-diphospho)-2-C-methyl-D-erythritol (CDP-ME) by the enzyme MEP cytidyltransferase. This compound is then transformed into 2-C-methyl-D-erythritol 2,4-cyclodiphosphate in a two-step reaction including phosphorylation of CDP-ME at position C2 followed by formation of 2,4-cyclodiphosphate under elimination of CMP [15, 16] . Further biochemical steps towards the terminal compound IPP are still unknown.
Materials and methods

Cloning of the P. aeruginosa genes encoding DXP synthase and DXP reductoisomerase
The DXP synthase gene (1884 bp) was ampli¢ed by PCR from genomic DNA of strain ATCC 27853 using the following primers (Interactiva, Germany) based on the genomic DNA sequence contig 54 (7/15/99) from the Pseudomonas Genome Project (www.pseudomonas.com): PaDXSfor 5P-GGT ACC GAA TTC ATG CCC AAG ACG CTC CAT GAG-3P including an EcoRI site (underlined) and PaDXSrev 5P-GGT ACC AGA TCT CTG CCG GTC GAG ACG CTG GCG-3P including a BglII site (underlined). PCR was carried out in a total volume of 20 Wl of PCR bu¡er (Promega) including 125 WM of each deoxynucleoside triphosphate, 10 pmol of each primer, 5% dimethyl sulfoxide and 1 U of Taq polymerase (Promega) in 30 cycles (95³C for 30 s, 60³C for 30 s, and 72³C for 120 s). The DXP reductoisomerase gene (1191 bp) was cloned in a similar way using the primers PaDXRfor 5P-AGA TCT ATG AGT CGA CCG CAG CGG ATC-3P (BglII site underlined) and PaDXRrev 5P-AGA TCT TAA AGC TTT GCC GGC GTG CCG GGT CAA CCA-3P (HindIII site underlined) for PCR.
Plasmid construction for expression of the recombinant
DXP synthase and DXP reductoisomerase in E. coli
The plasmid pDS-Pa-DXS was constructed by cleavage of the resulting PCR fragment with the restriction endonucleases EcoRI and BglII and ligation into a derivative of plasmid pQE-9 (Qiagen) containing these two restriction sites in appropriate positions in the multiple cloning site (pDS-Eco-neu, E. Beck, unpublished). Plasmid pQE-Pa-DXR was constructed by digesting the respective PCR fragment with BglII and HindIII and ligation into the vector pQE-30 (Qiagen) that had been cleaved with Bam-HI and HindIII.
2.3. Expression and puri¢cation of DXP synthase and DXP reductoisomerase E. coli TOP10FP (Invitrogen) cells transformed with pDS-Pa-DXS or pQE-Pa-DXR were grown at 37³C in standard I medium (Merck) supplemented with ampicillin (150 Wg ml 31 ) and protein expression was induced at OD 600 of 0.6 with 1 mM isopropyl L-D-thiogalactoside (IPTG) for 4 h. The bacteria were harvested by centrifugation, resuspended in bu¡er A (100 mM NaCl, 10 mM Tris^HCl (pH 8.0) and 2 mM 2-mercaptoethanol) and broken by ultrasonic treatment. Both histidine-tagged recombinant proteins were puri¢ed from the soluble fraction by a¤nity chromatography on Talon Super£ow resin (Clontech, Heidelberg, Germany) with an HPLC device (Gyncotech, Germering, Germany) under similar conditions. The columns were washed each with 10 mM imidazole in bu¡er A and the proteins eluted with 100 mM imidazole in bu¡er A. Protein concentrations were determined according to the method of Bradford [17] using bovine serum albumin as a standard.
Assay of DXP reductoisomerase
The DXP reductoisomerase assay was carried out as described [4] . The conversion of DXP to MEP by the puri¢ed recombinant DXP reductoisomerase from P. aeruginosa was monitored spectrophotometrically. A standard reaction mixture contained 1 Wg DXP reductoisomerase, 40 mM Tris^HCl (pH 7.5), 1 mM MnCl 2 , 1 mM DXP, and 0.3 mM NADPH in a total volume of 600 Wl.
Assay of DXP synthase
To establish a convenient spectrophotometric assay to measure DXP synthase activity, a coupled enzyme assay was developed. In this assay DXP generated by DXP synthase is further converted to MEP in a NADPH-dependent reaction by an excess of DXP reductoisomerase from E. coli that was cloned and puri¢ed in a similar way as described [18] . The NADPH consumption was monitored spectrophotometrically at 365 nm. A standard reaction mixture contained 40 mM Tris^HCl (pH 7.5), 0.3 mM NADPH, 1 mM MgCl 2 , 0.3 mM thiamine pyrophosphate, 6 mM DL-glyceraldehyde 3-phosphate, 3 mM pyruvate, 1 mM 2-mercaptoethanol, 100 mM NaCl, 27 Wg ( = 1 U) of E. coli DXP reductoisomerase and 3 Wg of DXP synthase from P. aeruginosa in a total volume of 600 Wl. For inhibition studies the reaction mixtures were preincubated with di¡erent concentrations of inhibitor for 5 min at 37³C and started by addition of pyruvate. 
Results and discussion
Identi¢cation of the P. aeruginosa genes encoding DXP synthase and DXP reductoisomerase
The genes of DXP synthase and DXP reductoisomerase from P. aeruginosa were identi¢ed by comparing the respective sequences from E. coli with the P. aeruginosa sequence database using the tblastn program (www.ncbi. nlm.nih.gov/BLAST/un¢nishedgenome.html). The amino acid sequences of DXP synthase and DXP reductoisomerase from P. aeruginosa revealed over 57% and 61% identity, respectively, with the corresponding E. coli enzymes. The genes were subsequently identi¢ed by PCR in six different P. aeruginosa strains including four clinical isolates and the strains ATCC 27853 and ATCC 9027. The ampli¢cation products derived from all strains tested appeared to be identical in size (Fig. 2) . The sequence data have been submitted to GenBank with the assigned accession number AF282878 for DXP synthase and AF282879 for DXP reductoisomerase.
Inhibition of DXP synthase
Using a coupled enzyme assay the activity of the puri¢ed recombinant DXP synthase from P. aeruginosa (Fig.  3) was monitored spectrophotometrically. The pH optimum of this assay was in range of pH 7.5^8.0 (data not shown). Searching for inhibitors of DXP synthase, £uoro-pyruvate was identi¢ed as a ¢rst inhibitor. The DXP synthase from P. aeruginosa was inhibited with an IC 50 of 400 WM (Fig. 4) . For comparison, the IC 50 of the respective enzyme from E. coli was 80 WM. The DXP synthase from E. coli was cloned into pQE9 vector and was puri¢ed in a similar way as described for the DXP synthase from P. aeruginosa. The activity of DXP reductoisomerase was not a¡ected by £uoropyruvate (data not shown). Fluoropyruvate is supposed to bind covalently to the active site of the DXP synthase in a comparable way as demonstrated for the pyruvate dehydrogenase component (E1) in the pyruvate dehydrogenase complex [19] .
Inhibition of DXP reductoisomerase
The activity of the DXP reductoisomerase from P. aeruginosa (Fig. 3) was monitored by NADPH consumption of the reaction in an established assay. Replacement of NADPH by NADH resulted in a decrease of the activity to about 1% of the original reaction rate (data not shown) as described for the E. coli enzyme [18] .
The DXP reductoisomerase from P. aeruginosa was inhibited by the antibiotics fosmidomycin and FR-900098 with an IC 50 of 150 nM for both drugs (Fig. 5) . Interest- Fig. 2 ingly, in a previous study the P. falciparum DXP reductoisomerase was inhibited 4 times more e¤ciently with FR-900098 than with fosmidomycin [4] . Fosmidomycin was supposed to be a mixed-type inhibitor (competitive and noncompetitive) of the DXP reductoisomerase from E. coli in an earlier study [5] .
Taken together with earlier data demonstrating that fosmidomycin was active in protecting mice challenged with P. aeruginosa [2] , the DXP pathway must be considered a valid target for the chemotherapy of P. aeruginosa infections. Using the convenient assay for DXP synthase described in this study together with the well established assay for DXP reductoisomerase we provide tools for easy and fast screening of potential inhibitors. In future work, the development of speci¢c and potent antibiotics targeting both DXP synthase and reductoisomerase may lead to synergistic drug combinations with increased therapeutic value.
